Vik Chopra
Stock Analyst at Wells Fargo
(2.44)
# 2,202
Out of 4,829 analysts
41
Total ratings
29.41%
Success rate
0.27%
Average return
Main Sectors:
Stocks Rated by Vik Chopra
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MASI Masimo | Maintains: Overweight | $205 → $190 | $156.57 | +21.35% | 9 | May 7, 2025 | |
| IART Integra LifeSciences Holdings | Maintains: Equal-Weight | $25 → $13 | $12.25 | +6.12% | 2 | May 6, 2025 | |
| HSIC Henry Schein | Maintains: Equal-Weight | $80 → $75 | $68.64 | +9.27% | 2 | May 6, 2025 | |
| CNMD CONMED | Maintains: Equal-Weight | $70 → $57 | $57.08 | -0.14% | 4 | May 1, 2025 | |
| ALGN Align Technology | Maintains: Overweight | $255 → $246 | $181.88 | +35.25% | 2 | May 1, 2025 | |
| SOLV Solventum | Maintains: Equal-Weight | $73 → $75 | $70.23 | +6.79% | 3 | Feb 28, 2025 | |
| XRAY DENTSPLY SIRONA | Maintains: Equal-Weight | $20 → $19 | $15.82 | +20.10% | 2 | Feb 28, 2025 | |
| GMED Globus Medical | Maintains: Overweight | $95 → $93 | $55.82 | +66.61% | 9 | Feb 21, 2025 | |
| NVST Envista Holdings | Maintains: Equal-Weight | $20 → $21 | $17.59 | +19.39% | 2 | Feb 6, 2025 | |
| NPCE NeuroPace | Maintains: Overweight | $15 → $13 | $12.95 | +0.42% | 2 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $26 → $19 | $12.21 | +55.61% | 1 | Aug 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $73 → $79 | $33.05 | +139.03% | 3 | Feb 23, 2024 |
Masimo
May 7, 2025
Maintains: Overweight
Price Target: $205 → $190
Current: $156.57
Upside: +21.35%
Integra LifeSciences Holdings
May 6, 2025
Maintains: Equal-Weight
Price Target: $25 → $13
Current: $12.25
Upside: +6.12%
Henry Schein
May 6, 2025
Maintains: Equal-Weight
Price Target: $80 → $75
Current: $68.64
Upside: +9.27%
CONMED
May 1, 2025
Maintains: Equal-Weight
Price Target: $70 → $57
Current: $57.08
Upside: -0.14%
Align Technology
May 1, 2025
Maintains: Overweight
Price Target: $255 → $246
Current: $181.88
Upside: +35.25%
Solventum
Feb 28, 2025
Maintains: Equal-Weight
Price Target: $73 → $75
Current: $70.23
Upside: +6.79%
DENTSPLY SIRONA
Feb 28, 2025
Maintains: Equal-Weight
Price Target: $20 → $19
Current: $15.82
Upside: +20.10%
Globus Medical
Feb 21, 2025
Maintains: Overweight
Price Target: $95 → $93
Current: $55.82
Upside: +66.61%
Envista Holdings
Feb 6, 2025
Maintains: Equal-Weight
Price Target: $20 → $21
Current: $17.59
Upside: +19.39%
NeuroPace
Nov 13, 2024
Maintains: Overweight
Price Target: $15 → $13
Current: $12.95
Upside: +0.42%
Aug 1, 2024
Maintains: Overweight
Price Target: $26 → $19
Current: $12.21
Upside: +55.61%
Feb 23, 2024
Maintains: Overweight
Price Target: $73 → $79
Current: $33.05
Upside: +139.03%